dc.contributorUniversidade Estadual Paulista (Unesp)
dc.date.accessioned2018-12-11T17:10:02Z
dc.date.available2018-12-11T17:10:02Z
dc.date.created2018-12-11T17:10:02Z
dc.date.issued2017-01-01
dc.identifierAnais Brasileiros de Dermatologia, v. 92, n. 1, p. 131-133, 2017.
dc.identifier1806-4841
dc.identifier0365-0596
dc.identifierhttp://hdl.handle.net/11449/174253
dc.identifier10.1590/abd1806-4841.20174602
dc.identifierS0365-05962017000100131
dc.identifier2-s2.0-85013378391
dc.identifierS0365-05962017000100131.pdf
dc.description.abstractHand-foot syndrome is a common cutaneous adverse effect associated with certain systemic chemotherapy drugs. It is characterized by erythema, edema, and burning sensation, especially over palmoplantar surfaces. We report the case of an elderly patient undergoing chemotherapy after a breast cancer surgery who developed symptoms two months after the start of the regimen. There are no studies that explore specific therapies. Suggestive therapy include reducing agent dosage, increasing the interval between cycles, or even stopping chemotherapy. Emollients, analgesics, and cold packs are described as effective. After alopecia and mucositis, hand-foot syndrome is the most common adverse dermatologic reaction to chemotherapeutic agents.
dc.languageeng
dc.relationAnais Brasileiros de Dermatologia
dc.relation0,520
dc.rightsAcesso aberto
dc.sourceScopus
dc.subjectAdjuvant chemotherapy
dc.subjectChemotherapy
dc.subjectDrug eruption
dc.subjectHand-foot syndrome
dc.titleDo you know this syndrome? Hand-foot syndrome
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución